Sound wave therapy could offer new relief for enlarged prostate
NCT ID NCT07194187
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 37 times
Summary
This study tests whether high-intensity focused ultrasound (HIFU) can safely shrink prostate tissue in men aged 45–80 with bladder outlet obstruction caused by an enlarged prostate (BPH). About 17 participants will receive the procedure and be followed for 6–12 months to see if urinary symptoms improve and if side effects are minimal. The goal is to offer a non-surgical option that controls symptoms without needing daily medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BPH are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Mount Sinai Union Square
New York, New York, 10003, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.